Clinical Trial

Blood And Tears in Alzheimer's Disease

Study acronym: BAT-AD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2024 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to investigate whether biomarkers of Alzheimer's disease can be found in tearfluid, as well as dried bloodspots in patients with Alzheimer's disease, other dementia diagnoses compared to controls.
Trial Details
NCT Number NCT06567431
Lead Sponsor Danish Dementia Research Centre
Conditions Neurodegenerative Diseases
Enrollment 600 participants
Start Date 2024-03-18
Primary Completion 2026-01-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-22